title: Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia.
authors.affiliation: Department of Human Retrovirology, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
authors.forename: Jaap
authors.initials: J
authors.lastname: Goudsmit
authors.forename: Johannes A
authors.initials: JA
authors.lastname: Bogaards
authors.forename: Suzanne
authors.initials: S
authors.lastname: Jurriaans
authors.forename: Hanneke
authors.initials: H
authors.lastname: Schuitemaker
authors.forename: Joep M A
authors.initials: JM
authors.lastname: Lange
authors.forename: Roel A
authors.initials: RA
authors.lastname: Coutinho
authors.forename: Gerrit Jan
authors.initials: GJ
authors.lastname: Weverling
mesh_terms: D018791:CD4 Lymphocyte Count; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000235:genetics; D015331:Cohort Studies; D006679:HIV Seropositivity / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development*; D006801:Humans; D008297:Male; D011379:Prognosis; D012367:RNA, Viral; D019713:Receptors, CCR5 / Q000235:genetics; D013997:Time Factors; D019562:Viral Load; D014766:Viremia
chemical_list: C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D012367:RNA, Viral; D019713:Receptors, CCR5